New paper
The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma from High-Risk Controls: A Retrospective Secondary Analysis
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New paper
Acidic microenvironment promotes pancreatic cancer cell survival via Akt phosphorylation-mediated suppression of apoptosis.
Why it was picked newest record on or before this date
New paper
Targeting RAS for Pancreatic Cancer Interception
Why it was picked newest record on or before this date
New paper
Clinical quality of large language model answers to questions about pancreatic cancer
Why it was picked newest record on or before this date
New paper
Association between Serum Human Satellite II RNA and miR-21-5p Levels and Time to Pancreatic Cancer Diagnosis in a Prospective Population-based Study.
Why it was picked newest record on or before this date
Also today
New paper
Bioengineered extracellular vesicles integrating anti-EphA2 recognition and oxaliplatin delivery for pancreatic cancer therapy.
New paper
Inflammatory memory inactivates AMPK-stimulated DDR1 degradation to enable pancreatic cancer growth.
New paper
IRE1α–XBP1s signaling links lipid homeostasis to hypoxic maladaptation and KRAS inhibitor responses in pancreatic ductal adenocarcinoma
New paper
Genetic evaluation of encorafenib-associated kinases RAF1 and MAPK8 in pancreatic cancer: Exploratory mediation by circulating immune traits.
Editor’s note
Not in the data yet: changes to existing records. Status changes, newly posted results and retractions need a history of each record, which is not collected yet. Until then the digest lists new records only.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.